G protein subunit levels in fibroblasts from familial Alzheimer's disease patients: lower levels of the high molecular weight Gsα isoform in patients with decreased β-adrenergic receptor stimulated cAMP formation
Open Access
- 1 August 1997
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 232 (1) , 33-36
- https://doi.org/10.1016/s0304-3940(97)00572-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Abnormalities in Alzheimer’s Disease Fibroblasts Bearing the APP670/671 MutationNeurobiology of Aging, 1997
- Differential regulation of adenylyl cyclase in fibroblasts from sporadic and familial Alzheimerʼs disease cases with PS1 and APP mutationsNeuroReport, 1997
- Mixed signals in Alzheimer's diseaseTrends in Neurosciences, 1996
- Intracellular Cyclic AMP Inhibits Constitutive and Phorbol Ester‐Stimulated Secretory Cleavage of Amyloid Precursor ProteinJournal of Neurochemistry, 1996
- β-amyloid peptides enhance binding of the calcium mobilising second messengers, inositol(1,4,5)trisphosphate and inositol-(1,3,4,5)tetrakisphosphate to their receptor sites in rat cortical membranesNeuroscience Letters, 1995
- Increased Inositol 1,4,5‐Trisphosphate Accumulation Correlates with an Up‐Regulation of Bradykinin Receptors in Alzheimer's DiseaseJournal of Neurochemistry, 1995
- Increased β‐amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutationFEBS Letters, 1994
- Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brainBrain Research, 1994
- Reduced Protein Kinase C Immunoreactivity and Altered Protein Phosphorylation in Alzheimer's Disease FibroblastsArchives of Neurology, 1989
- A standard procedure for cultivating human diploid fibroblastlike cells to study cellular agingJournal of Tissue Culture Methods, 1980